Skip to main content
. 2013 Aug;6(4):421–425. doi: 10.1093/ckj/sft065

Fig. 1.

Fig. 1.

Graph summarizing key laboratory results. Thin arrows indicate doses of cisplatin; bold arrows indicate doses of eculizumab.